Thurs Jan 9th, the US Stock Markets will be closed in observance of a national day of mourning for former President Jimmy Carter. Read the press release here. Regular trading hours will resume tomorrow.
Ra Pharmaceuticals Inc (RARX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | RARX | AMGN | BMY | GILD | VRTX |
| Company | Ra Pharmaceuticals Inc | Amgen Inc | Bristol-Myers Squibb Company | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | NASDAQ | NASDAQ |
| Open | 47.99 | 261.97 | 56.98 | 90.68 | 410.71 |
| High | 48.01 | 264.25 | 57.05 | 90.68 | 412.36 |
| Low | 47.98 | 259.82 | 56.05 | 89.00 | 407.24 |
| Last | 48.00 | 264.21 | 56.81 | 89.14 | 412.11 |
| Change | -0.02 | +2.15 | -0.33 | -1.49 | +3.79 |
| % Change | -0.03% | +0.82% | -0.58% | -1.64% | +0.93% |
| Volume | 3,864,600 | 2,421,900 | 11,995,900 | 8,054,100 | 1,173,800 |
| 20-Day Average Volume | 1,869,975 | 3,692,505 | 11,675,340 | 6,373,685 | 1,954,515 |
| Previous Close | 48.01 | 262.06 | 57.14 | 90.63 | 408.32 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 46.03 | 264.46 | 56.92 | 92.13 | 425.74 |
| 20-Day Raw Stochastic | 99.68% | 44.35% | 46.46% | 2.48% | 34.74% |
| 20-Day Relative Strength | 56.47% | 38.99% | 50.18% | 43.71% | 39.51% |
| Weighted Alpha | +21.70 | -17.79 | +18.95 | +11.62 | -10.26 |
| Today's Opinion | 56% Buy | 88% Sell | 40% Buy | 56% Buy | 88% Sell |
| Previous Opinion | 56% Buy | 88% Sell | 88% Buy | 64% Buy | 88% Sell |
| Last Month's Opinion | 80% Buy | 72% Sell | 100% Buy | 100% Buy | 24% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.91% since 03/25/20 | +1.37% since 12/31/24 | +0.44% since 12/31/24 | -3.50% since 12/31/24 | +2.34% since 12/31/24 |
| Low | 46.34 on 03/26/20 | 257.05 on 01/06/25 | 55.94 on 01/06/25 | 89.00 on 01/08/25 | 399.00 on 01/06/25 |
| High | 48.02 on 03/31/20 | 265.21 on 01/07/25 | 57.67 on 01/07/25 | 92.83 on 01/02/25 | 412.36 on 01/08/25 |
| 1-Month | |||||
| %Chg | +2.64% since 02/28/20 | -3.07% since 12/06/24 | -4.33% since 12/06/24 | -3.25% since 12/06/24 | -10.82% since 12/06/24 |
| Low | 40.30 on 03/18/20 | 253.30 on 12/19/24 | 55.04 on 12/13/24 | 89.00 on 01/08/25 | 377.85 on 12/19/24 |
| High | 48.02 on 03/31/20 | 280.00 on 12/09/24 | 59.76 on 12/09/24 | 94.65 on 12/11/24 | 476.46 on 12/10/24 |
| 3-Month | |||||
| %Chg | +2.27% since 12/31/19 | -16.83% since 10/08/24 | +8.25% since 10/08/24 | +4.61% since 10/08/24 | -10.20% since 10/08/24 |
| Low | 40.30 on 03/18/20 | 253.30 on 12/19/24 | 51.31 on 10/15/24 | 84.17 on 10/11/24 | 377.85 on 12/19/24 |
| High | 48.02 on 03/31/20 | 329.17 on 10/11/24 | 61.08 on 11/11/24 | 98.90 on 11/11/24 | 519.88 on 11/08/24 |
| 6-Month | |||||
| %Chg | +112.27% since 10/01/19 | -15.17% since 07/08/24 | +42.06% since 07/08/24 | +31.96% since 07/08/24 | -14.48% since 07/08/24 |
| Low | 22.25 on 10/08/19 | 253.30 on 12/19/24 | 39.71 on 07/09/24 | 66.34 on 07/09/24 | 377.85 on 12/19/24 |
| High | 48.02 on 03/31/20 | 346.85 on 07/25/24 | 61.08 on 11/11/24 | 98.90 on 11/11/24 | 519.88 on 11/08/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 2,271,555 | 142,021,584 | 115,220,736 | 111,092,152 | 106,130,272 |
| Shares Outstanding, K | 47,329 | 537,533 | 2,028,177 | 1,246,266 | 257,529 |
| Annual Sales | 3,000,000 | 28,190,000,000 | 45,006,000,000 | 27,116,000,000 | 9,869,200,000 |
| Annual Net Income | -102,690,000 | 6,717,000,000 | 8,025,000,000 | 5,665,000,000 | 3,619,600,000 |
| Last Quarter Sales | 3,000,000 | 8,503,000,000 | 11,892,000,000 | 7,545,000,000 | 2,771,900,000 |
| Last Quarter Net Income | -24,980,000 | 2,830,000,000 | 1,211,000,000 | 1,253,000,000 | 1,045,400,000 |
| 60-Month Beta | 1.04 | 0.56 | 0.45 | 0.18 | 0.40 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 5.58 on 10/30/24 | 1.80 on 10/31/24 | 2.02 on 11/06/24 | 4.38 on 11/04/24 |
| Latest Earnings Date | 05/14/20 | 02/04/25 | 02/06/25 | 02/11/25 | 02/03/25 |
| Most Recent Dividend | N/A | 2.250 on 11/18/24 | 0.620 on 01/03/25 | 0.770 on 12/13/24 | N/A |
| Next Ex-Dividends Date | N/A | 02/14/25 | 01/03/25 | 12/13/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 13.63 | 48.84 | 20.46 | 0.00 |